참고문헌
- Price DL. New perspectives on Alzheimer's disease. Neuroscience 9: 489-512 (1986)
- Kasa P, Rakonczay Z, Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52: 511-535 (1997) https://doi.org/10.1016/S0301-0082(97)00028-2
- Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403-1406 (1976)
- Sims NR, Bowen DM, Allen SJ, Smith CC, Neary D, Thomas DJ. Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem. 40: 503-509 (1983) https://doi.org/10.1111/j.1471-4159.1983.tb11311.x
- DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann. Neurol. 32: 625-632 (1992) https://doi.org/10.1002/ana.410320505
- Fu AL, Zhang XM, Sun MJ. Antisense inhibition of acetylcholinesterase gene expression for treating cognition deficit in Alzheimer's disease model mice. Brain Res. 1066: 10-15 (2005) https://doi.org/10.1016/j.brainres.2005.09.063
- Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M. A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease. Prog. Neuro-Psychoph. 27: 555-561 (2003) https://doi.org/10.1016/S0278-5846(03)00053-8
- Rahman AU, Choudhary MI. Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure Appl. Chem. 73: 555-560 (2001) https://doi.org/10.1351/pac200173030555
- Oh MH, Hougton PJ, Whang WK, Cho JH. Screening of Korean herbal medicines used to improve cognitive function for anticholinesterase activity. Phytomedicine 11: 544-548 (2004) https://doi.org/10.1016/j.phymed.2004.03.001
- Schulz V. Ginkgo extract or cholinesterase inhibitors in patients with dementia: What clinical trial and guidelines fail to consider. Phytomedicine 10: 74-79 (2003) https://doi.org/10.1078/1433-187X-00302
- Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine 14: 289- 300 (2007) https://doi.org/10.1016/j.phymed.2007.02.002
- Yoshikawa M, Morikawa T, Toguchida I, Harima S, Matsuda H. Medicinal flowers. II. Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes, kikkanols D, D monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L. Chem. Pharm. Bull. 48: 651-656 (2000) https://doi.org/10.1248/cpb.48.651
- Matsuda H, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase. Chem. Pharm. Bull. 50: 972-975 (2002) https://doi.org/10.1248/cpb.50.972
- Zhu S, Yang Y, Yu H, Ying Y, Zou G. Chemical composition and antimicrobial activity of the essential oils of Chrysanthemum indicum. J. Ethnopharmacol. 96: 151-158 (2005) https://doi.org/10.1016/j.jep.2004.08.031
- Lim SS, Han SM, Kim SY, Bae YS, Kang IJ. Isolation of acetylcholinesterase inhibitors from the flowers of Chrysanthmum indicum Linne. Food Sci. Biotechnol. 16: 265-269 (2007)
- Beatty WW, Buters N, Janowsky DS. Patterns of memory failure after scopolamine treatment implications for cholinergic hypothesis of dementia. Behav. Neural. Biol. 45: 196-211 (1986) https://doi.org/10.1016/S0163-1047(86)90772-7
- Morris RG. Development of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11: 47-60 (1984) https://doi.org/10.1016/0165-0270(84)90007-4
- Ellman GL, Lourtney DK, Andres V, Gmelin G. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95 (1961) https://doi.org/10.1016/0006-2952(61)90145-9
- Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275 (1951)
- Galgani F, Bocquene G, Cadiou Y. Evidence of variation of cholinesterase activity in fishes along a pollution gradient in the North Sea. Mar. Ecol.-Prog. Ser. 91: 77-82 (1992) https://doi.org/10.3354/meps091077
- Ebert U, Kirch W. Scopolamine model of dementia: Electroencephalogram findings and cognitive performance. Eur. J. Clin. Invest. 28: 944-949 (1998) https://doi.org/10.1046/j.1365-2362.1998.00393.x
- Lim SY, Suzuki H. Effect of dietary docosahexaenoic acid on mazelearning ability in aged mice fed n-3 fatty acid deficient diet. Food Sci. Biotechnol. 14: 788-792 (2005)
- Jann MW. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12 (2000) https://doi.org/10.1592/phco.20.1.1.34664
- Rubioa J, Dangb H, Gongb M, Liub X, Chenb S, Gonzalesa GF. Aqueous and hydroalcoholic extracts of Black Maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice. Food Chem. Toxicol. 45: 1882-1890 (2007) https://doi.org/10.1016/j.fct.2007.04.002
- Saxenaa G, Singha SP, Palb R, Singha S, Pratapc R, Natha C. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol. Biochem. Be. 86: 797-805 (2007) https://doi.org/10.1016/j.pbb.2007.03.010